No Data
No Data
No Data
No Data
No Data
Investors in Integral Diagnostics (ASX:IDX) Have Unfortunately Lost 40% Over the Last Three Years
Yahoo FinanceApr 23 23:45 ET
How AI Could Boost This ASX 300 Healthcare Stock
ASX 300 healthcare stock Integral Diagnostics Ltd (ASX: IDX) is up 1.43% to $2.49 per share on Thursday.
The Motley FoolApr 18 00:28 ET
While Institutions Own 40% of Integral Diagnostics Limited (ASX:IDX), Retail Investors Are Its Largest Shareholders With 44% Ownership
Yahoo FinanceApr 3 16:18 ET
Capital Allocation Trends At Integral Diagnostics (ASX:IDX) Aren't Ideal
Yahoo FinanceMar 14 00:11 ET
Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight
09:05 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight Price (AUD): $2.23, Change: $-0.06, Percent Change:
MT NewswiresMar 5 21:05 ET
Integral Diagnostics Price Target Raised 13% to A$2.20/Share by Citi
Integral Diagnostics Price Target Raised 13% to A$2.20/Share by Citi
Dow JonesFeb 21 17:33 ET
No Data
No Data
73674721 : great read thanks